Almac’s One Unified Clinical Trial Supply Solution has one objective to guarantee the study drug is with the patient at the right time while ensuring the complete chain of custody and minimising wastage of drug from production to destruction.
Up to 60% of clinical development time and 40% of cost are spent on patient recruitment. Data can help, but simply accessing more data only muddies your decision making. With Covance, you get the right analysis on the right data to empower your studies. Recruit eligible patients that fit your protocol faster, identify and secure proven and/or new sites, forecast and measure progress more efficiently. With Covance’s proprietary data, your program hits its mark.
In order to demonstrate a deeper commitment to clinical trial transparency than the law requires, some sponsors are choosing to provide additional information about their portfolio of clinical trials on a dedicated website. TrialScope Engage can help sponsors manage clinical trial content that is being prepared for disclosure on their own sites.
TrialScope EngageTM enables clinical trial sponsors to engage with patients and the public via a user-friendly, high impact website to openly share clinical trial information and results, demonstrating leadership in transparency while optimizing trial recruitment and retention.
We’ve mastered the details so you don’t have to. Partner with a company that knows drug development including trial design, clinical development plans, protocol writing, working with regulators, and medical oversight of clinical trials.
Download the at a Glance Schedule for DIA 2019 Global Annual Meeting - San Diego - June 23-27.
What's happening at DIA in 2019? Download the DIA Events and Training Calendar to see where and when DIA will be hosting conferences, meetings, short courses, and training opportunities for you and your team.
Our analytical and research services evaluate the performance of formulations using a whole range of advanced investigative testing procedures. They’re a hugely important part of our work, forming a valuable foundation for future developments and innovations.
As the cost and complexity of global clinical studies increases and the number of biosimilar (or biogenetic) studies continue to rise, the availability of comparator products can make or break your clinical trial’s supply chain.
It’s the final interface between good manufacturing practice and the world of good clinical practice, but the importance of clinical storage and distribution is all too often overlooked.
|
|
|
|
|
|
|
|
|